Enhance your practice with CME and tools that focus on diseases and conditions impacting the female patient.
SERENA-6: Acting on ESR1 Mutations in Advanced Breast Cancer
Erica L. Mayer, MD, MPH
Ongoing Trials in Oral Targeted Strategies in Breast Cancer
Aditya Bardia, MD, MPH, FASCO
22nd Annual Women’s Health Annual Visit (WHAV)
Multiple dates & locations available
Shared Goals, Shared Gains: Align With Patient Preferences
Christyn Edmundson, MD
Gil I. Wolfe MD, FAAN
Escalate With Intention: Stepwise, Target-Anchored Moves
Minimal By Design: Define MSE Endpoints
Treat. Target. Transform: Applying Treat-to-Target Principles in the Management of Generalized Myasthenia Gravis (gMG)
Target Locked in gMG: Why T2T Matters
The 2-Point Signal: Apply ≥2-Point Rule
Turning Flares Into Function: Flag Uncontrolled Disease
The IgG Clock: Redose Using IgG Kinetics
Precision Starts Before Birth: Reimagining Fetal Care Through FcRn Immune Modulation
Kenneth J. Moise Jr., MD
Kara B. Markham, MD
Primary Biliary Cholangitis: Shining Light on an "Invisible" Female Health Burden
Gideon Hirschfield, MB, BChir, PhD
Marlyn Mayo, MD
Diagnosing and Treating IBS: It Begins With One Simple Question
Brooks D. Cash, MD, AGAF, FACG, FACP, FASGE
Kimberly D. Orleck, PA-C
Women’s Sleep Health – Addressing Gaps in OSA Diagnosis and Treatment Across Life Stages
Alison Kole, MD, MPH, FACCP
Ghada Bourjeily, MD, FCCP
Rashmi Nisha Aurora, MD
Audrey Wells, MD
The Alloimmune Disorders of Pregnancy
Karin J. Blakemore, MD
Emilie L. Vander Haar
ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
When to Begin FcRn: Initiation Criteria, Key Evidence
FcRn: Same Class, Different Paths—Spot Agent Differentiators
Early Diagnosis: Its Pivotal Role in Optimizing Outcomes in Patients With Endometriosis – Psychosocial and Physical Consequences
Lee P. Shulman, MD, FACMG, FACOG
Linda Bradley, MD
Samantha Denäe
Pre- and Postoperative Use of GnRH Antagonists
Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
Clinical Considerations for the Diagnosis of Endometriosis
James A. Simon, MD, CCD, NCMP, IF, FACOG
Capturing the Impact of Endometriosis on Health-Related QoL: The Role of Patient Questionnaires
It’s Not Just Black and White: Seeing the Full Spectrum of Endometriosis Cases
Melissa Simon, MD
Casey Joe Hinds
Rapid Data Pulses From ASCO 2026: Emerging Data on Oral Targeted Strategies in Breast Cancer
Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT): Overcoming Diagnostic and Therapeutic Challenges
Cut to the Chase: Why Not Treat Endometriosis With GnRH Antagonists First?
Sawsan As-Sanie, MD
The Integral Role of GnRH Antagonists in the Management of Endometriosis
Changing the Mindset in the Management of Endometriosis: Hitting the Pause Button on Surgical Procedures and Expanding the Role of GnRH Antagonists
Why Are the Fetus and Placenta Not Rejected by the Mother? New Insights Into Maternal Anti-Fetal Rejection
Roberto Romero, MD, DMedSci
Alloimmune Thrombocytopenia in the Fetus and Newborn
James B. Bussel, MD
Targeting the Fc Receptor Pathway to Treat Red Blood Cell Alloimmunization
Loading...
We're glad to see you're enjoying Omnia Education… but how about a more personalized experience?
Press cancel to remain on Omnia Education. Press the link below or the continue button to keep going.